Jubilant Life Sciences has issued Commercial Papers (CPs) of Rs 90 crore on January 17, 2018. The CPs are not proposed to be listed. The aggregate amount of Commercial Papers including this issue outstanding as on date is Rs 90 crore.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.